Severe Asymptomatic Aortic Stenosis

Similar documents
Valvular Guidelines: The Past, the Present, the Future

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

Spotlight on Valvular Heart Disease Guidelines

Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

Indicator Mild Moderate Severe

Nothing to Disclose. Questions. Disclosure Asymptomatic Severe Aortic Stenosis: (When) Should One Intervene? Paul Wood at the Nathanson Lecture, 1958

Natural History and Echo Evaluation of Aortic Stenosis

Exercise Testing/Echocardiography in Asymptomatic AS

Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies

Shahbudin H. Rahimtoola MB, FRCP, MACP, MACC, FESC, D.Sc. (Hon.)

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

Usually we DON T need to go beyond the gradient

Outcome of elderly patients with severe but asymptomatic aortic stenosis

Aortic Valvular Stenosis

Aortic stenosis aetiology: morphology of calcific AS,

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

MitraClip: Why, How, and For Whom?

Secondary Mitral Regurgitation: When Should We Intervene?

Aortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis?

Asymptomatic Valvular Disease:

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Low Gradient Severe? AS

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

TAVR in patients with. End-Stage CKD or in Renal Replacement Therapy:

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

PERCEVAL S. Giovanni Troise MD CARDIAC SURGERY UNIT. SORIN GROUP 2011 ANALYST AND INVESTOR MEETING Milano - March 21st G.

A patient with aortic stenosis and LV dysfunction EuroECHO & Other Imaging Modalities 2012 Athens, Greece

Improving Quality of Care for Patients with Heart Valve Disease

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

CARDIAC PHYSIOLOGIST LED AORTIC STENOSIS SURVEILLANCE CLINIC

Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis?

Aortic Stenosis.

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

TAVR : Caring for your patients before and after TAVR

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Aortic Valve Stenosis: Medical Treatment, Still in the Pipeline?

Title of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis

What Determines the Outcome of Aortic Stenosis?

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Asymptomatic Severe Aortic Stenosis with Left Ventricular Dysfunction: Watchful Waiting or Valve Replacement?

Medical Treatment for AS. Disclosures. Valvular Heart Disease. Aortic Stenosis. Severe Symptomatic AS Survival. Disease Progression in Aortic Stenosis

Aortic Stenosis and Perioperative Risk With Non-cardiac Surgery

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

Welcome 17 Michigan TAVR Participating Hospitals!

TAVR: Echo Measurements Pre, Post And Intra Procedure

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

A Health Care Professional s Guide Aortic Stenosis in Seniors

Affecting the elderly Requiring new approaches. Echocardiographic Evaluation of Hemodynamic Severity. Increasing prevalence Mostly degenerative

Comprehensive Echo Assessment of Aortic Stenosis

Cardiac catheterisation in AS

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Risk stratification of severe aortic stenosis according to new guidelines: long term outcomes

Low Gradient AS: Multi-Imaging Modalities

The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD

Disclosures. LGH TAVR: Presentation Outline 2/2/2016. Updates in Transcatheter Aortic Valve Replacement (TAVR) and the LGH Experience

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Timing for surgery in asymptomatic aortic valvular diseases a matter of controversy

The Transcatheter Aortic Valve Replacement (TAVR)Program at Southcoast Health. Adam J. Saltzman, MD Cardiovascular Care Center

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

The Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease

The best in heart valve disease Aortic valve stenosis

Calcific aortic stenosis is the third most common cause of aortic valve disease in developed

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Hypertension in Aortic Valve Disease

New in Heart Failure SGK autumn session 2012

Clinical material and methods. Clinical Departments of 1 Radiology II and 2 Cardiology, Innsbruck Medical University, Innsbruck, Austria

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Stress Testing in Valvular Disease

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

10/1/2016. Constrictive Pericarditis Unique Hemodynamics. What s New in Pericardial Disease? Case-based Discussion

: mm 86 mm EF mm

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Sténose aortique à Bas Débit et Bas Gradient

The TAVI Journey: Update on Evidence And Future trials

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

Low gradient severe aortic stenosis with preserved left ventricular ejection fraction

ESC / EACTS new valvular guidelines- Update

2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease

Operate NOT every BAV aorta at 5 cm. Markus Schwerzmann, MD

Potential conflicts of interest

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Aortic stenosis (AS) is common with the aging population.

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

TAVR in 2017 What we know? What to expect?

Low Gradient AS Normal LVEF

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

Michigan Society of Echocardiography 30 th Year Jubilee

Cured of Cancer but now Let s Heal the Heart An exploration into the effects of cancer on the heart

Transcription:

Severe Asymptomatic Aortic Stenosis The Clinician s Perspective Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital No Relationships to Disclose

Severe Asymptomatic Aortic Stenosis The Clinician s Perspective Are asymptomatic patients with severe AS really asymptomatic?

Severe Aortic Stenosis Indications for valve replacement Exercise test: Symptoms Hypotension class I class I

Severe Aortic Stenosis Indications for valve replacement Exercise test: Symptoms Hypotension class I class I Should asymptomatic patients with severe AS undergo AVR? when they are really asymptomatic?

Vmax: 4.6 m/s Mean : 52 mmhg AVA: 0.7 sq cm Severe AS: >4.0 m/s >40 mmhg <1.0 sq cm

Aortic Stenosis 84 year old man with severe AS Watchful waiting? * More data (more testing)? Aortic valve replacement? * Wait until he develops symptoms in 5-6 years and then recommend TAVR?

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% High volume centers: 6.0% Otto 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Otto et al. Circulation 1997;95:2262-2270

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% High volume centers: 6.0% Otto Rosenhek 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Otto et al. Circulation 1997;95:2262-2270 Rosenhek et al. N Engl J Med 2000;343:611-617

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% High volume centers: 6.0% Otto Rosenhek Pellikka 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Otto et al. Circulation 1997;95:2262-2270 Rosenhek et al. N Engl J Med 2000;343:611-617 Pellikka et al. Circulation 2005;111:3290-2395

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% Stewart High volume centers: 6.0% Otto Rosenhek Pellikka 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Otto et al. Circulation 1997;95:2262-2270 Rosenhek et al. N Engl J Med 2000;343:611-617 Pellikka et al. Circulation 2005;111:3290-2395 Stewart et al. Eur Heart J 2010;31:2216-2222

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 0 Low volume centers: 13.0% Stewart High volume centers: 6.0% Otto 0 0 1 2 3 4 5 0 1 2 3 4 5 Time (years) Rosenhek Pellikka Nistri Otto et al. Circulation 1997;95:2262-2270 Rosenhek et al. N Engl J Med 2000;343:611-617 Pellikka et al. Circulation 2005;111:3290-2395 Stewart et al. Eur Heart J 2010;31:2216-2222 Nistri et al. Am J Cardiol 2012;109;718-723

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Vmax > 4.0 m/s Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% Rosenhek High n=128 volume centers: 6.0% 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Rosenhek et al. N Engl J Med 2000;343:611-617

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Average hospital mortality: 8.8% 60 40 20 Low volume centers: 13.0% High n=128 volume centers: 6.0% p<0.001 No or mild calcification Moderate or severe calcification 0 0 1 2 3 4 5 0 0 1 2 3 4 5 Time (years) Rosenhek et al. N Engl J Med 2000;343:611-617

Natural History of Severe Asymptomatic AS Event-Free Survival (%) Medicare 80 data Average hospital mortality: 8.8% 60 40 20 0 Low volume centers: 13.0% High n=198 volume centers: 6.0% p<0.001 0 0 1 2 3 4 5 0 1 2 3 4 5 Time (years) Vmax 4.0 5.0 m/s Vmax 5.0 5.5 m/s Vmax >5.5 m/s Rosenhek et al. Circulation 2010;121:151-156

Asymptomatic Aortic Stenosis Indications for valve replacement: Very severe AS: Vmax 5 m/s

Asymptomatic Aortic Stenosis Indications for valve replacement: Very severe AS: Vmax 5 m/s Rapid progression and low surgical risk class IIb

Asymptomatic Aortic Stenosis Indications for valve replacement: Very severe AS: Vmax 5 m/s Rapid progression and low surgical risk class IIb Very severe AS: Vmax >5.5 m/s

Asymptomatic Aortic Stenosis Indications for valve replacement: Very severe AS: Vmax 5 m/s Rapid progression and low surgical risk class IIb Very severe AS: Vmax >5.5 m/s Severe valve calcification and rate of progression 0.3 m/s / year

Asymptomatic Aortic Stenosis Indications for valve replacement: Very severe AS: Vmax 5 m/s Rapid progression and low surgical risk class IIb Very severe AS: Vmax >5.5 m/s Severe valve calcification and rate of progression 0.3 m/s / year Markedly elevated BNP Increase in gradient with exercise >20 mmhg Excessive LVH class IIb

Aortic stenosis The ACC/AHA guidelines have lowered the threshold for surgery in asymptomatic patients with AS Severity of AS Severity of calcification Left ventricular function Exercise response

Aortic stenosis The ACC/AHA guidelines have lowered the threshold for surgery in asymptomatic patients with AS Severity of AS Severity of calcification Left ventricular function Exercise response BNP?

Aortic stenosis The ACC/AHA guidelines have lowered the threshold for surgery in asymptomatic patients with AS Survival (percent) 80 80 60 40 20 BNP ratio <1.0 1.0-1.9 2.0-2.9 3.0 Severity of AS Severity of calcification Left ventricular function Exercise response BNP? 00 0 1 12 3 24 5 36 7 48 9 10 5 Time (years) Clavel et al, J Am Coll Cardiol 2014;63:2016-2025